Home > Insider Trading > Filing (0001209191-15-037170)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1289098	C Terrence Kearney	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-04-27	28,125	$56.99	28,125	No	4	M	Direct
Common Stock	Acquisiton	2015-04-27	20,000	$53.85	48,125	No	4	M	Direct
Common Stock	Acquisiton	2015-04-27	20,000	$59.55	68,125	No	4	M	Direct
Common Stock	Disposition	2015-04-27	26,593	$127.50	41,532	No	4	S	Direct
Common Stock	Disposition	2015-04-27	16,295	$128.12	25,237	No	4	S	Direct
Common Stock	Disposition	2015-04-27	4,500	$129.94	20,737	No	4	S	Direct
Common Stock	Disposition	2015-04-27	8,800	$130.58	11,937	No	4	S	Direct
Common Stock	Disposition	2015-04-27	3,969	$131.76	7,968	No	4	S	Direct
Common Stock	Disposition	2015-04-27	5,668	$132.82	2,300	No	4	S	Direct
Common Stock	Disposition	2015-04-27	2,300	$133.63	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-04-27	28,125	$0.00	28,125	$56.99
Common Stock	Stock Option (right to buy)	Disposition	2015-04-27	20,000	$0.00	20,000	$53.85
Common Stock	Stock Option (right to buy)	Disposition	2015-04-27	20,000	$0.00	20,000	$59.55

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,875	2021-05-16	No	4	M	Direct
0	2021-05-31	No	4	M	Direct
0	2022-05-31	No	4	M	Direct

Footnotes

Transaction made pursuant to Mr. Kearney's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $127.50 (range $126.87 to $127.86).
Mr. Kearney undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $128.12 (range $127.87 to $128.83).
Open market sales reported on this line occurred at a weighted average price of $129.94 (range $129.16 to $130.15).
Open market sales reported on this line occurred at a weighted average price of $130.58 (range $130.16 to $131.14).
Open market sales reported on this line occurred at a weighted average price of $131.76 (range $131.25 to $132.20).
Open market sales reported on this line occurred at a weighted average price of $132.82 (range $132.32 to $133.30).
Open market sales reported on this line occurred at a weighted average price of $133.63 (range $133.36 to $134.09).
The option vests in 16 quarterly installments from 05/17/2011.
Fully vested.